A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Exact Sciences Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 75,109 shares of EXAS stock, worth $3.24 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
75,109
Previous 66,459 13.02%
Holding current value
$3.24 Million
Previous $4.92 Million 5.51%
% of portfolio
0.08%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $486,735 - $638,110
8,650 Added 13.02%
75,109 $5.19 Million
Q4 2023

Feb 14, 2024

SELL
$59.06 - $75.72 $1.64 Million - $2.11 Million
-27,822 Reduced 29.51%
66,459 $4.92 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $286,641 - $430,526
4,347 Added 4.83%
94,281 $6.43 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $695,748 - $1.06 Million
11,100 Added 14.08%
89,934 $8.44 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $98,438 - $147,626
-2,086 Reduced 2.58%
78,834 $5.35 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $1.4 Million - $2.45 Million
46,059 Added 132.12%
80,920 $4.01 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $1.11 Million - $1.72 Million
34,861 New
34,861 $1.13 Million
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $216,936 - $464,393
-6,092 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $138,028 - $197,930
-2,398 Reduced 28.24%
6,092 $426,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $131,587 - $182,734
1,815 Added 27.19%
8,490 $661,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $175,065 - $240,657
1,940 Added 40.97%
6,675 $637,000
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $3,090 - $4,595
33 Added 0.7%
4,735 $589,000
Q1 2021

May 17, 2021

SELL
$116.57 - $155.01 $132,190 - $175,781
-1,134 Reduced 19.43%
4,702 $620,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $102,299 - $145,957
-1,027 Reduced 14.96%
5,836 $773,000
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $91,150 - $127,512
-1,250 Reduced 15.41%
6,863 $700,000
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $501 - $834
9 Added 0.11%
8,113 $705,000
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $79,552 - $219,219
2,099 Added 34.95%
8,104 $470,000
Q4 2019

Feb 14, 2020

BUY
$77.66 - $99.74 $466,348 - $598,938
6,005 New
6,005 $555,000
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $324,518 - $439,861
-3,591 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $3.71 Million - $4.89 Million
-41,400 Reduced 92.02%
3,591 $424,000
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $58,509 - $91,096
944 Added 2.14%
44,991 $3.9 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $12,384 - $18,267
221 Added 0.5%
44,047 $2.78 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $2.33 Million - $3.89 Million
-48,316 Reduced 52.44%
43,826 $3.46 Million
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $1.38 Million - $2.55 Million
-36,472 Reduced 28.36%
92,142 $5.51 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $3.44 Million - $4.97 Million
-86,423 Reduced 40.19%
128,614 $5.19 Million
Q4 2017

Feb 14, 2018

SELL
$46.49 - $60.51 $5.67 Million - $7.38 Million
-121,882 Reduced 36.18%
215,037 $11.3 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $12.5 Million - $15.9 Million
336,919
336,919 $15.9 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.